Loading people...
Alyssa Reisner is an Investor and Lead Director at CVS Health Ventures in New York, New York. In this capacity, she leads a deal team that sources, evaluates, and executes strategic investments for the corporate venture capital arm, which initially launched with a $100 million allocation to back early-to-growth stage digital health startups. Prior to joining the venture fund following its formal 2021 formation, she worked in corporate development at both CVS Health and Aetna, focusing on mergers, acquisitions, and strategic partnerships. She previously served on the digital innovation team at CVS Health to support new business models, and she holds a Bachelor of Science in Business Administration from Babson College. Her current investment focus centers on healthcare technology, care delivery innovation, and building strategic relationships across the nutrition, senior care, big tech, and retail sectors.
Alyssa Reisner stands as a pivotal investor within CVS Health, a leading healthcare innovation company. In her role, Alyssa is instrumental in advancing CVS Health's mission to make healthcare more accessible, affordable, and effective through strategic investments. She is actively involved in identifying, evaluating, and supporting emerging companies and technologies that promise to transform the healthcare landscape.
Her primary investment focus areas are deeply aligned with CVS Health's broader strategic objectives. This includes a strong emphasis on digital health solutions, such as telehealth platforms, remote patient monitoring, and AI-driven diagnostic tools that enhance patient engagement and care coordination. Alyssa also targets investments in health technology that streamline operations, improve data analytics, and personalize patient experiences. Furthermore, she explores opportunities in pharmacy innovation, consumer health and wellness, and value-based care models that drive better health outcomes at lower costs. Her work contributes directly to CVS Health's efforts to integrate care, expand services, and provide holistic health solutions to millions.
While specific details of her career background are not widely publicized, investors in her position typically possess a robust foundation in finance, venture capital, or healthcare strategy. It is common for professionals like Alyssa to have prior experience in corporate development, mergers and acquisitions, or management consulting within the healthcare sector, equipping them with a deep understanding of market dynamics and growth opportunities. This background enables her to critically assess potential investments, understand complex regulatory environments, and identify companies with strong leadership and scalable solutions.
Regarding notable investments, Alyssa Reisner's work is part of CVS Health's broader strategic investment initiatives, which often include investments made through CVS Health Ventures. While individual portfolio details attributed directly to her may be proprietary, CVS Health Ventures generally invests in early-stage and growth-stage companies that are innovating across the healthcare continuum. These investments aim to foster partnerships and integrate new capabilities that complement CVS Health's existing services, ranging from primary care and chronic disease management to mental health and preventative wellness. The impact of her work is seen in the continuous evolution of CVS Health's offerings and its commitment to leading the next generation of healthcare solutions.
Alyssa Reisner is an investor at CVS Health, focusing on strategic investments in innovative healthcare companies and technologies.
Alyssa Reisner invests in areas such as digital health, healthcare technology, pharmacy innovation, consumer health, and solutions that align with CVS Health's mission to improve patient care and accessibility.
Alyssa Reisner works as an investor at CVS Health, a leading healthcare innovation company.
